Trial intelligence / Profile preview

Validation of Dyskinesia Rating Scales in Parkinson's Disease

NCT01071395Phase 4Completed

Sponsor
Rush University Medical Center
Start
Jan 2010
Primary completion
Apr 2012
Modality
Small Molecules
Countries
4
01

Overview

A Phase 4 trial of amantadine in dyskinesia, sponsored by Rush University Medical Center. Started Jan 2010; status: completed.

02

Drugs

amantadine
03

Conditions

dyskinesia

Beyond the preview

Go deeper on NCT01071395.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01071395.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call